Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS
2024-515001-26-00Phase 4Authorised
- Sponsor
- Region Zealand
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clindamycin, amoxicillin and clavulanic acid in bloodstream infection (BSI) and bacterial disease, sponsored by Region Zealand. Primary endpoints: Hospitalization for bloodstream infection within 6 months and Hospitalization ≥ 3 days due to infection within 6 months. Planned start Jul 2024; status: authorised.
02
Drugs
clindamycinamoxicillinclavulanic acid
03
Conditions
bloodstream infection (BSI)bacterial disease
Beyond the preview
Go deeper on 2024-515001-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515001-26-00.